$35.63
0.270.76%
Ult. Agg.: Oct 21, 2:05 PM
$35.36
N/A
IDEAYA Biosciences (IDYA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.08 | $-1.00 | $-0.98 | $-0.55 |
| Actual | $-1.22 | $-1.11 | $-0.94 | $1.33 |
| Surprise | -13.0% | -11.0% | +4.08% | +341.8% |
| Revenue | ||||
| Estimate | $7.4M | $6.1M | $9.2M | $87.7M |
| Actual | $8.9M | $6.6M | $10.9M | $207.8M |
| Surprise | +18.9% | +8.10% | +18.3% | +137.1% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.18 | $-1.12 | $-1.38 | $-1.35 |
| Revenue | ||||
| Consensus | $7.8M | $21.7M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $-1.22 | $-1.08 | -13.0 % |
| Q1 | May 5, 2026 | $-1.11 | $-1.00 | -11.0 % |
| Q4 | Feb 17, 2026 | $-0.94 | $-0.98 | 4.08 % |
| Q3 | Nov 4, 2025 | $1.33 | $-0.55 | 341.8 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $8.86M | $7.45M | 18.9 % |
| Q1 | May 5, 2026 | $6.56M | $6.07M | 8.10 % |
| Q4 | Feb 17, 2026 | $10.88M | $9.20M | 18.3 % |
| Q3 | Nov 4, 2025 | $207.83M | $87.67M | 137.1 % |